Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tawanda Gumbo

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|July 27, 2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Beki T Magazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis ProgramsMarlanka A Zuur, Jotam G Pasipanodya, Dick van Soolingen, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistanceAurelia M Schmalstieg, Shashikant Srivastava, Serkan Belkaya, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus InfectionBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
Ebiomedicine|August 17, 2016
The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismZoe Rogers, Hiwot Hiruy, Jotam G Pasipanodya, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2019
Once-a-week tigecycline for the treatment of drug-resistant TBDevyani Deshpande, Gesham Magombedze, Shashikant Srivastava, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus DiseaseBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
Ebiomedicine|February 13, 2016
Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High MortalityJotam G Pasipanodya, Mwenya Mubanga, Mpiko Ntsekhe, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
The Pediatric Infectious Disease Journal|August 11, 2020
Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in ChildrenShashikant Srivastava, Johanna van Zyl, Kayle Cirrincione, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|July 27, 2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis PatientsChawangwa Modongo, Jotam G Pasipanodya, Beki T Magazi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2018
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis ProgramsMarlanka A Zuur, Jotam G Pasipanodya, Dick van Soolingen, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistanceAurelia M Schmalstieg, Shashikant Srivastava, Serkan Belkaya, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus InfectionBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
Ebiomedicine|August 17, 2016
The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismZoe Rogers, Hiwot Hiruy, Jotam G Pasipanodya, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2019
Once-a-week tigecycline for the treatment of drug-resistant TBDevyani Deshpande, Gesham Magombedze, Shashikant Srivastava, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus DiseaseBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
Ebiomedicine|February 13, 2016
Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High MortalityJotam G Pasipanodya, Mwenya Mubanga, Mpiko Ntsekhe, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseBeatriz E Ferro, Shashikant Srivastava, Devyani Deshpande, et al.
The Pediatric Infectious Disease Journal|August 11, 2020
Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in ChildrenShashikant Srivastava, Johanna van Zyl, Kayle Cirrincione, et al.
Pageof 21